Is the Interferon-Gamma Release Assay (IGRA) test the same as the Quantiferon test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The IGRA test is not the same as the Quantiferon test, although Quantiferon is a specific brand of IGRA test. The IGRA test is a general term that refers to a type of test that measures the immune response to Mycobacterium tuberculosis, while Quantiferon is a specific commercial test that uses this technology 1. Other IGRA tests, such as T-SPOT.TB, also exist and work on similar principles but use different methodologies 1.

Key Differences and Similarities

  • All IGRA tests, including Quantiferon, detect the immune response to M. tuberculosis rather than the bacterium itself, making them more specific than the traditional tuberculin skin test, especially in people who have received the BCG vaccine 1.
  • IGRA tests are preferred over tuberculin skin tests in certain populations, such as immunosuppressed individuals and those with cancer, due to their higher sensitivity and specificity 1.
  • Quantiferon-TB Gold and Quantiferon-TB Gold Plus are commercial IGRA tests manufactured by Qiagen that detect tuberculosis infection by measuring interferon-gamma release from T-cells in response to TB antigens 1.
  • Healthcare providers should specify which particular IGRA test they are ordering, as laboratory procedures and interpretation may differ slightly between the various commercial IGRA products 1.

Clinical Implications

  • IGRA tests, including Quantiferon, are useful for diagnosing M. tuberculosis infection in adults and children, and can be used for surveillance purposes and to identify persons likely to benefit from treatment 1.
  • A positive IGRA test result should be followed by an evaluation to rule out active TB, including clinical history, physical examination, and chest X-radiograph or thoracic CT scan 1.
  • The choice of IGRA test may depend on the specific clinical context and the availability of testing facilities 1.

Test Characteristics

  • IGRA tests require only a single patient visit for specimen collection, with results typically available within 24 hours 1.
  • The tests measure the immune response to M. tuberculosis antigens, rather than the presence of the bacterium itself, making them more specific than traditional tests 1.

From the Research

IGRA Test and Quantiferon Comparison

The Interferon-Gamma Release Assay (IGRA) test and the Quantiferon test are related but not exactly the same.

  • The IGRA test is a type of blood test that measures the immune system's response to tuberculosis (TB) bacteria by detecting the release of interferon-gamma [ 2 ].
  • The Quantiferon test is a specific type of IGRA test that uses a blood sample to detect the presence of TB infection [ 3 ].

Key Differences and Similarities

Some key points to consider:

  • Both IGRA and Quantiferon tests are used to diagnose latent TB infection [ 4 ].
  • The Quantiferon test is a specific type of IGRA test that has been widely used and studied [ 5 ].
  • Other types of IGRA tests, such as the T-SPOT.TB test, are also available and may have similar or different performance characteristics compared to the Quantiferon test [ 6 ].

Clinical Use and Interpretation

In clinical practice, the choice of IGRA test may depend on various factors, including:

  • The specific clinical scenario and patient population [ 2 ].
  • The availability and cost of different IGRA tests [ 3 ].
  • The performance characteristics of different IGRA tests, including sensitivity, specificity, and agreement with other diagnostic tests [ 4 ].

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.